Considerations regarding a meta-analysis of ceftazidime-avibactam versus other antimicrobial agents for treatment of multidrug-resistant pseudomonas aeruginosa
Competing interests
The authors declare no competing interests.
Ethical approval
No need for this letter to the editor.
Conflict of interest disclosure
The authors have no competing interests to declare.
留言 (0)